SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.438
EU - Europa 2.441
AS - Asia 1.953
SA - Sud America 68
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 12.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.394
CN - Cina 805
SG - Singapore 751
DE - Germania 688
UA - Ucraina 562
IT - Italia 368
TR - Turchia 339
GB - Regno Unito 284
FI - Finlandia 259
SE - Svezia 114
BR - Brasile 60
BE - Belgio 41
CA - Canada 40
RU - Federazione Russa 32
FR - Francia 31
HK - Hong Kong 20
NL - Olanda 20
LT - Lituania 16
IN - India 7
CZ - Repubblica Ceca 6
IR - Iran 6
AR - Argentina 4
BG - Bulgaria 4
JP - Giappone 4
CL - Cile 3
HR - Croazia 3
IQ - Iraq 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GA - Gabon 1
IE - Irlanda 1
KR - Corea 1
MM - Myanmar 1
MX - Messico 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.910
Salva come PNG Salva come JPEG
Città #
Fairfield 1.109
Woodbridge 1.076
Houston 652
Jacksonville 612
Ann Arbor 559
Chandler 526
Ashburn 525
Seattle 401
Wilmington 392
Santa Clara 385
Singapore 369
Cambridge 352
Munich 225
Izmir 193
Nanjing 178
Beijing 170
Helsinki 135
Milan 125
Princeton 118
San Diego 109
Boardman 101
New York 79
Shanghai 72
Dearborn 56
Nanchang 56
Shenyang 51
Falls Church 44
Los Angeles 44
Brussels 40
Bremen 34
Hebei 32
Auburn Hills 29
Jiaxing 29
Changsha 28
Ferrara 28
Mountain View 27
San Mateo 27
Jinan 26
Falkenstein 23
Tianjin 23
London 22
Mcallen 22
Norwalk 22
Hong Kong 20
Philadelphia 20
Redwood City 20
Addison 19
Kunming 18
Montréal 17
Zhengzhou 17
Toronto 14
Indiana 12
Ningbo 12
Tappahannock 12
Des Moines 10
Bologna 8
Augusta 7
Düsseldorf 7
Frankfurt am Main 7
Guangzhou 7
Ottawa 7
Padova 7
Verona 7
Florence 6
Hounslow 6
Lanzhou 6
Leawood 6
Orange 6
Redmond 6
Washington 6
São Paulo 5
Ardabil 4
Brno 4
Changchun 4
Hangzhou 4
Jyväskylä 4
Monmouth Junction 4
Prescot 4
Sofia 4
Taizhou 4
Belo Horizonte 3
Carapicuíba 3
Chiswick 3
Edinburgh 3
Ferrara di Monte Baldo 3
Fuzhou 3
Hefei 3
Tokyo 3
Zagreb 3
Bolzano 2
Bondeno 2
Brescia 2
Busto Arsizio 2
Chongqing 2
Clifton 2
Curitiba 2
Montechiarugolo 2
New Bedfont 2
Olomouc 2
Piscataway 2
Totale 9.506
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 290
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 229
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 228
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 181
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 177
A new selective antagonist of the nociceptin receptor 158
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 157
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 157
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 155
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 153
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 151
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 148
Pharmacological characterization of nociceptin receptor: an in vitro study 146
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 145
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 143
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 142
A new ligand for the urotensin II receptor 142
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 142
Ala scan analogues of HOE 140. Synthesis and biological activities 141
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 138
Effects of vasoactive agents in healthy and diseased human saphenous veins 138
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 135
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 134
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 131
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 131
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 128
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 127
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 126
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 126
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 125
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 124
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 124
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 123
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 122
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 122
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 121
Structure-activity study at positions 3 and 4 of human neuropeptide S. 121
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 120
B1 and B2 kinin receptors in various species 118
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 118
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 118
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 118
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 117
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 115
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 115
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 114
Characterization of endothelin receptors in the human umbilical artery and vein 114
Pharmacology of the Kallikrein-Kinin system 114
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 114
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 113
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 113
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 113
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 113
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 113
Pharmacological characterisation of novel kinin B2 receptor ligands 112
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 112
null 111
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 110
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 109
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 109
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 108
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 108
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 106
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 106
Structure-activity relationship study on human urotensin II 106
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 106
Receptors for kinins in the human isolated umbilical vein 104
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 103
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 103
Nociceptin/orphanin FQ receptor ligands, 102
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 102
null 99
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 99
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 98
null 98
Characterization of the human vascular kinin B2 receptor by binding assays. 97
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 97
Pharmacology of nociceptin and its receptor: a novel therapeutic target 96
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 95
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 95
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 94
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 92
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 92
null 92
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 91
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 91
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 90
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 89
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 89
null 88
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 88
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 87
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 86
Highly potent full and partial agonists and anatagonists of the nociceptin/orphanin FQ receptor 84
null 84
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT(1) and AT(2) receptors 81
ANTAGONISTI DEL RECETTORE UT E LORO USI TERAPEUTICI 80
null 79
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 78
Totale 11.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020485 0 0 0 0 0 0 0 0 0 262 145 78
2020/20211.495 142 158 60 214 68 159 53 177 30 166 204 64
2021/20221.308 44 137 96 98 87 56 73 72 57 94 123 371
2022/20231.347 126 52 62 173 225 177 113 100 199 7 68 45
2023/2024641 77 78 38 16 41 137 21 42 13 13 14 151
2024/20251.950 55 51 208 109 340 319 133 178 407 150 0 0
Totale 13.012